Previous Article | Next Article ![]()
Infection and Immunity, November 1999, p. 5958-5966, Vol. 67, No. 11
Departments of Obstetrics and
Gynecology1 and
Pathology,3 University of Minnesota,
and Minneapolis Medical Research
Foundation,2 Minneapolis, Minnesota
Received 24 March 1999/Returned for modification 19 May
1999/Accepted 25 August 1999
Urinary tract infections (UTIs) are associated with approximately
27% of premature births. Escherichia coli is the most
frequent causal agent of UTIs and expresses virulence factors,
including surface adhesins that recognize specific host tissue
receptors. We have reported that E. coli Dr adhesin
recognizes decay-accelerating factor as the host tissue receptor and
that these receptors are increased during pregnancy. Induction of
pathogenesis is a cumulative effect of the host-pathogen relationship
involving specific host factors and virulence characteristics of the
invading organism. Recently, an experimental model of chronic
pyelonephritis has been developed with E. coli bearing Dr
adhesin (E. coli Dr+) in nonpregnant
lipopolysaccharide hyporesponder C3H/HeJ mice. In this study, we
investigated the role of E. coli Dr+ on the
outcome of pregnancy in C3H/HeJ mice. Groups of pregnant mice were
infected with E. coli Dr+ or its isogenic
mutant which does not bear the Dr adhesin (E. coli
Dr Approximately 1 of every 10 babies
in the United States is born prematurely, and prematurity is the
leading cause of death among infants before their first birthday
(2). In addition to being small, premature babies are
developmentally unprepared for life, which can result in physical and
mental disabilities. Premature babies are more likely to have
respiratory problems during childhood and a higher incidence of
learning disabilities and problems with speech, hearing, and vision.
The increased risk of preterm birth is very high, and the cost to
society is overwhelming from financial and health perspectives
(11).
Preterm labor has been associated with bacterial infection. The most
common infections associated with preterm labor are intrauterine infections and urinary tract infections (UTIs) (4, 6, 12, 25,
43). The relationship between asymptomatic bacteriuria and
preterm birth has been well documented (37), and recently, Schultz et al. (38) reported that UTIs are associated with
approximately 27% of premature births. UTIs, including asymptomatic
bacteriuria, cystis, and pyelonephritis are the most common and
frequently encountered medical complications of pregnancy
(28). Although UTIs may be asymptomatic in pregnancy,
physiological changes that occur during pregnancy predispose women
patients to a very high risk of developing acute pyelonephritis,
resulting in considerable maternal morbidity and mortality.
Additionally, UTIs during pregnancy may adversely affect the fetus
(1). Preterm labor and low birth weight have been cited as
the significant adverse outcomes in pregnant women with asymptomatic
bacteriuria (24, 29, 43). A meta-analysis by Romero et al.
(37) showed that nonbacteriuric patients had only two-thirds
the risk of low-birth-weight infants and half the risk of preterm
delivery compared to patients with untreated asymptomatic bacteriuria.
The most common pathogen isolated from pregnant women with UTIs is
Escherichia coli; it has been reported to be the primary pathogen in 80% of UTI cases (17). An important factor in
the pathogenesis of UTIs, as in any bacterial infection, is bacterial virulence. The ability of certain uropathogenic E. coli to
adhere to uroepithelium is largely responsible for its virulence. This adherence is considered to be a prerequisite for the initiation of the
disease process. E. coli's ability to adhere is mediated by
structures called adhesins, which are present on the bacterial cell
surface. Our previous studies and reports by other investigators indicate that E. coli and other bacteria express different
surface adhesins that mediate the attachment of these pathogens to
various human or animal cells through specific tissue receptors
(3, 21, 31). Host-pathogen interactions through these
specific receptors determine the extent of pathogenesis.
Considerable progress has been made in characterizing adhesins in
E. coli (41, 42, 44). Studies of E. coli adhesins and their respective specific tissue receptors have
established an adhesin-ligand-based mechanism of ascending UTI
(32). In 1988, Nowicki et al. (31) reported that
one such adhesin, isolated from a female patient with UTI, bound to the
Dr blood group antigen; they proposed the term Dr hemagglutinin for
this bacterial adhesin. Our earlier studies showed that
decay-accelerating factor (DAF) also known as CD55, a complement
regulatory protein, is expressed in human endometrium and may serve as
the receptor for E. coli Dr adhesin (21). Studies
have also shown that E. coli Dr adhesin may recognize DAF,
located in the tubular basement membrane and Bowman's capsule,
resulting in colonization of renal tissues (33-35, 45). Our
earlier studies have shown that there is an upregulation of DAF during
the third trimester of pregnancy (26). Also, it has been
reported that there is a higher incidence of E. coli bearing
Dr adhesin (E. coli Dr+) during the third
trimester of pregnancy in women with gestational pyelonephritis
(36).
Recently, Goluzsko et al. (15) reported the development of
an experimental model of chronic pyelonephritis with E. coli Dr+ in nonpregnant lipopolysaccharide (LPS)-hyporesponder
C3H/HeJ mice. Intrauterine infections with E. coli
Dr+ have been reported to result in a high death rate in
pregnant rats compared to that of nonpregnant rats (30).
There is an increasing emphasis on the role of E. coli
Dr+ in the pathogenesis of UTIs, particularly during
pregnancy. However, the precise role of Dr adhesin in UTI during
pregnancy has not been investigated. Therefore, in this study, we
investigated the role, if any, of E. coli Dr+ in
the induction of preterm labor. Pregnant C3H/HeJ mice were experimentally infected with either E. coli Dr+
or its isogenic mutant (which does not express Dr adhesin) (E. coli Dr Animals.
Timed pregnant LPS-hyporesponsive C3H/HeJ mice were
obtained from Jackson Laboratories, Bar Harbor, Maine. Use of C3H/HeJ mice with decreased response to LPS made it possible to elucidate the
role of non-LPS factors such as Dr adhesin in pathogenicity and its
effect on the outcome of pregnancy. Timed pregnant mice arrived in our
animal facility on day 5 of pregnancy. All animals were housed under
pathogen-free conditions in the animal facility of the Minneapolis
Medical Research Foundation (MMRF). Once infected, the mice were placed
in separate cages in a clean room. All experimentation described in
this study was approved by the MMRF Institutional Animal Care and Use Committee.
Bacterial strains.
Two bacterial strains of E. coli Dr+ IH11128 and Dr14 were used to infect the
pregnant mice. Bacterial strain IH11128, which expresses Dr adhesin,
has been isolated from a female patient with a symptomatic UTI
(32). Dr14 is an isogenic mutant of wild-type IH11128 and
does not express Dr adhesin (15). Both strains were kindly
provided by Bogdan Nowicki of The University of Texas Medical Branch, Galveston.
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Experimental Gestational Pyelonephritis Induces
Preterm Births and Low Birth Weights in C3H/HeJ Mice
![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
) by urethral catheterization. Nearly 90% of pregnant
mice infected with E. coli Dr+ delivered
preterm (before 90% gestation) compared to 10% of mice infected with
E. coli Dr
and none of the mice treated with
phosphate-buffered saline (PBS). Also, there was a significant
reduction in fetal birth weight in the E. coli
Dr+-infected group compared to the E. coli
Dr
- and PBS-treated groups (P = 0.003).
This experimental model of E. coli Dr+-induced
preterm delivery in mice may help in understanding the molecular
mechanisms involved in UTI-induced preterm labor involving bacterial adhesins.
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
), and their effects on the outcome of
pregnancy and fetal birth weight were determined.
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
Induction of experimental UTI in pregnant C3H/HeJ mice by bladder
catheterization with E. coli Dr+.
Groups
of pregnant C3H/HeJ mice were infected on day 7 of pregnancy (35%
gestation) with E. coli Dr+ or E. coli Dr
by urethral catheterization and instillation
of a single dose of bacterial suspension (0.05 ml of a suspension with
an optical density at 600 nm of 1) into the urinary bladder, as
previously described (15). The control group received
sterile PBS. Animals were anesthetized with isoflurane in a sealed
glass jar for 30 s. The inoculum of E. coli
Dr+ or E. coli Dr
strains was
instilled into the bladder through a soft polyethylene catheter with an
outer diameter of 0.30 mm (Norton Performance Plastics, Akron, Ohio)
adapted to a needle on a tuberculin syringe (0.4 by 20 mm). A 0.05-ml
sample of the appropriate microbial inoculum was injected. The catheter
was then immediately withdrawn without further manipulations. The mice
were placed in individual cages and allowed free access to food and
drink under a 12-h day-night cycle. The animals were monitored every 4 to 6 h for symptoms of preterm labor, such as bleeding, fetal
loss, or other sickness. The animals were also monitored for changes in
body weight during pregnancy. Any delivery occurring on or before day
18 of gestation was considered preterm (before 90% gestation). The
survival of the pups delivered by these mice, either term or preterm,
was monitored.
Determination of fetal birth weight in infected mice.
To
investigate whether infection with E. coli Dr+
or E. coli Dr
affects the weight of the
developing fetuses in pregnant C3H/HeJ mice, we performed a set of
experiments in which 22 pregnant mice were infected with E. coli Dr+, E. coli Dr
, or PBS
on day 7 of pregnancy (at 35% gestation), as described above. The mice
were monitored every 6 to 8 h for symptoms of preterm labor. The
mice were sacrificed on day 17 of pregnancy (at 85% gestation), and
the fetuses were carefully removed and weighed.
Quantitative tissue culture. Quantitative tissue culture was performed at two time points: (i) a group of infected mice completing delivery, preterm or term, that was sacrificed immediately after the delivery and (ii) another group of infected mice that was sacrificed, at an earlier time point, on day 17 (80% gestation). The fetus, spleen, and renal tissues were collected and subjected to bacteriological cultures, and the E. coli bacteria recovered were quantitated and typed for adhesin expression. The tissue from each mouse was homogenized separately in 0.5 ml of sterile PBS and plated on Luria agar and MacConkey plates for isolation of live bacteria. The bacterial counts were recorded as CFU per gram of tissue.
The E. coli bacteria recovered from the tissues were typed for the presence of Dr adhesin, and its specificity was tested by agglutination test, using human O erythrocytes and anti-DAF antibody (Wako Chemicals USA Inc., Richmond, Va.).Histological analysis of tissues. The kidneys and placental and fetal tissues collected for histological analysis were fixed overnight in formalin, embedded in paraffin, and sectioned for immunohistochemical analysis and stained with hematoxylin and eosin. Unstained paraffin-embedded tissue sections were stained with Gram stain for detection of bacteria.
Inflammation scores of 0 to 4+ were assigned based on the percentage involvement of the structure or tissue being examined on the basis of polymorphonuclear cell (PMN) or mononuclear cell (MNC) infiltration as follows: 1+, 5% involvement; 2+, 5 to 15% involvement; 3+, 15 to 25% involvement; and 4+, >25% involvement. The overall score for histopathological grading of pyelonephritis was based on pelvic, interstitial, and tubular involvement. Scoring for percentage tissue involvement in the placental or fetus was also determined as described above. Kidney, placental, or fetal tissue samples without lesions were graded as 0. All tissue samples were coded and read blind by one observer (J.T.C.).Statistical analysis. All data were recorded as means ± standard errors of the means per subgroup. Individual comparisons among the different groups were assessed by the Student's t test. Significance in the incidence of preterm birth among groups was evaluated by the Fisher exact test.
| |
RESULTS |
|---|
|
|
|---|
Induction of gestational UTI in pregnant mice and its effect on
outcome of pregnancy, survival of pups, and dissemination of
infection.
We observed that the group of mice infected with
E. coli Dr+ showed signs of preterm labor. The
mice in this group started delivering from day 11 on, and most
delivered by day 18 of gestation. Table 1
gives the results on the outcome of pregnancy and survival of pups
after the delivery in the E. coli-infected and control groups of mice. The mice undergoing preterm labor showed signs of
vaginal bleeding followed by preterm parturition, delivering both live
and dead pups. A significant number of mice infected with E. coli Dr+ delivered preterm compared to the E. coli Dr
-infected group or the control group. The
difference among the groups was statistically significant. Thus,
experimental infection with E. coli Dr+ in
C3H/HeJ mice led to preterm labor.
|
and those in the control group did not die after the
delivery. There was a high mortality rate among the pups born to the
mothers infected with E. coli Dr+. These pups
were born dead or died within a few days of premature delivery. A
significant number of the pups in the E. coli
Dr+ group were born prematurely and were found dead
compared to the E. coli Dr
group or the
control group (Table 1). The difference in the mortality rate of pups
born to the E. coli Dr+ group or E. coli Dr
group and the control group was significant.
To investigate the extent of E. coli infection, recovery of
E. coli from kidney and fetal tissues was examined in a
group of infected mice upon completion of delivery. The results of the bacterial tissue cultures are given in Table
2. The mean bacterial CFU/gram of kidney
tissue was significantly higher in the E. coli Dr+ group than in the E. coli Dr
group (P = 0.004). The kidney tissues obtained from all
the mice in E. coli Dr+- and E. coli
Dr
-infected groups demonstrated positive bacterial
cultures.
|
-infected group (P
0.02). In the E. coli Dr+-infected group,
all fetuses (10 of 10) showed positive bacterial cultures, compared to
only 33% fetuses (4 of 12) in the E. coli Dr
-infected group. The remaining fetal cultures from the
E. coli Dr
group were sterile, indicating
limited dissemination of E. coli Dr
to
the developing fetus compared to E. coli Dr+ group.
Effect of E. coli infection on fetal birth weight and
dissemination of infection on day 17 of gestation.
E.
coli Dr+ infection in pregnant mice affects the fetal
birth weight outcome as demonstrated by the low fetal birth weight of
the E. coli Dr+-infected group compared to that
of the E. coli Dr
group or the control group.
There was a significant difference in the fetal weights in the E. coli Dr+, E. coli Dr
, and
control groups. The difference in fetal weight between the groups was
statistically significant (P = 0.003). Table 2 provides the mean fetal weight and bacterial culture results found for the three groups.
-infected mice sacrificed on day 17 (at 85% of gestation) exhibited positive bacterial cultures with
growth of a significant number of bacteria (Table 2). However, the
difference between the mean CFU/gram of E. coli in kidney
tissue, at this time point, among the two E. coli-infected
groups was not significant (P > 0.05).
A significantly higher number of E. coli bacteria were
recovered from fetal tissues of the E. coli Dr+
group than from those of the E. coli Dr
group
(P = 0.05). Fetal tissue from all six fetuses tested
from the E. coli Dr+ group showed E. coli growth, compared to only two of seven fetuses in the E. coli Dr
group. The remaining fetal tissue cultures
in the E. coli Dr
group were sterile.
Spleens recovered from mice in each group were cultured for bacterial
counts. Four of 8 mice in the E. coli Dr+ group
had >108 CFU per spleen, whereas only 2 of 8 mice in the
E. coli Dr
group had >108 CFU per
spleen. The difference between the two groups was not significant
(P > 0.05).
Histopathological studies. Histopathological evaluation of the kidney, fetus, and placenta was performed on infected mice, after sacrificing one group of animals on completion of delivery and another group on day 17 of gestation, to evaluate the evolution of pathogenicity after infection with E. coli.
(i) Kidney histopathology.
The kidney histopathology
inflammatory scores in infected and control group of mice are listed in
Table 3, and representative histopathology of the E. coli Dr+ group of mice
is shown in Fig. 1A, B, and C and
representative histopathology of the E. coli
Dr
or control group is shown in Fig. 1D.
|
|
group. This inflammation also extended to the tubules
and interstitium of the kidney (Fig. 1C). Gram staining of the tissue
sections also revealed bacterial infiltration in the tubules and
glomeruli of the kidney. Tubular and interstitial involvement of the
kidney tissue was absent in the E. coli Dr
group of mice. The majority of the animals in the E. coli
Dr
group had cleared the infection and did not show any
MNC infiltration (Fig. 1D). Also, no inflammatory cells were observed
in kidney sections obtained from control animals.
In the groups of animals sacrificed on day 17 gestation after
infection, the mean inflammatory score of acute and chronic inflammation in renal pelvis of the E. coli Dr+
group of mice was higher than that seen in the E. coli
Dr
group where only a few mice had inflammatory cells.
However, on comparison between the two groups, a statistically
significant level was not achieved. None of the groups showed renal
tubular involvement at this time point. Interstitial involvement of the kidney was observed in five of eight animals of the E. coli
Dr+ group and in only two of eight animals of the E. coli Dr
group. The difference between the mean
inflammatory score of the interstitium in the E. coli
Dr+ and E. coli Dr
groups was not
statistically significant. Kidney tissue sections from the control
group of mice showed no inflammation.
(ii) Placental histopathology.
The placental histopathology in
the E. coli Dr+ group sacrificed after delivery
revealed infiltration of PMNs and bacteria in the placental tissue of
all eight animals and the mean inflammatory score were significantly
higher (P < 0.0001) than observed in the E. coli Dr
group where only four of eight animals
showed a few inflammatory cells in the placenta (Table 3). In the
severely infected placenta, very few villi were left (Fig.
2). A majority of the animals in the
E. coli Dr
group had placental histology
comparable to the animals in the control group. Histology was not
performed on the placenta of mice sacrificed on day 17 of gestation.
|
(iii) Fetal histopathology.
All fetal cross sections obtained
from all eight mice sacrificed after the delivery in the E. coli Dr+ group showed higher infiltration of PMNs and
bacteria which is shown by the higher mean inflammatory scores compared
to the scores obtained from the E. coli Dr
group. The differences between the two groups were statistically significant (P < 0.0001). All the fetuses in the
E. coli Dr+ group also showed impaired
development of the organs (Fig. 3A). Only
three of eight fetuses in the E. coli Dr
group
showed PMN infiltration, while the rest of the fetal sections revealed
no inflammation or impaired development. The fetuses of the control
group showed no inflammation or impaired organ development (Fig. 3B).
|
, or control group of mice,
sacrificed on day 17 of gestation revealed any inflammation with PMN
infiltration or poor organ development. However, only two of eight
fetuses in the E. coli Dr+-infected group that
had delivered preterm revealed inflammation and poor organ development.
| |
DISCUSSION |
|---|
|
|
|---|
An appreciable number of pregnancies that culminate in preterm labor are associated with infectious processes. The molecular mechanisms that regulate the inflammatory response to bacterial infection have only recently become the focus of study (7-9). The information about the bacterial properties involved in this process, the nature of the inflammatory mediators, and the functional consequences of the response are very limited. To understand the pathophysiology of infection-induced preterm labor, various in vivo animal model studies have used LPS to induce preterm labor. Numerous reports describe deleterious effect of dose-dependent bacterial LPS in pregnant animals resulting in fetal death or abortion (5, 20, 36, 39). In contrast to the findings in animal studies, the quantity of endotoxin required to stimulate prostaglandin production in human amnion has not been found in the amniotic fluid of women with intra-amniotic infections. This suggests that other factors may be involved in the initiation of preterm labor (13). Thus, studies so far do not completely explain the relationship between infections, such as ascending UTI, and preterm labor. Several pieces of evidence suggest that Dr adhesin, present on the uropathogenic E. coli plays an important role in the pathogenesis of UTIs. Dr adhesins occur more frequently in UTI-associated E. coli isolates than in fecal isolates (10, 19), and the presence of Dr adhesin at the time of first UTI has been associated with an increased risk of a second UTI (14). Experimental ascending UTI with E. coli Dr+ leads to chronic pyelonephritis in C3H/HeJ mice, and E. coli Dr+ bacteria are found to colonize the interstitial space of the mouse kidney, an area that is not directly available for bacteria colonizing the renal pelvis (15). Also, recently it has been reported that E. coli Dr+ possess slow-invasive properties in the HeLa epithelial cell line infected in vitro by this bacteria (16).
This study describes, for the first time, the role of adhesin-based
gestational UTI induced in LPS hyporesponder animals using E. coli Dr+ where animals infected with E. coli Dr+ delivered preterm and animals infected with
E. coli Dr
were protected and delivered at
term. Bacterial tissue cultures revealed overwhelming infiltration by
bacteria and a systemic spread in pregnant animals infected with
E. coli Dr+. Excessive colonization in the
kidneys, placentae, fetuses, and spleens of E. coli
Dr+-infected animals indicate chronic colonization and a
suppressed clearing mechanism in these animals. The findings of
increased isolation of bacterial cultures in the placentae and fetuses
of the E. coli Dr+-infected animals indicate the
transplacental transfer of virulent bacteria to the developing fetus.
We also observed that the congenital infection in the pups of the
animals that were infected with E. coli Dr+
leads to low fetal birth weight and poor organ development, thereby causing an increase in the fetal death rate. The restricted growth of
the fetus and the poor development of the organs observed in fetal
sections of the E. coli Dr+ group may be a
result of infection-induced placental changes that left few placental
villi to support fetal development. We need to further understand this
mechanism. This model may provide an opportunity to understand the
molecular mechanisms and clinical outcomes of UTIs during pregnancy.
Histopathological studies done on kidney, placenta, and fetus confirmed
the differences in clinical outcome observed between the E. coli Dr+, E. coli Dr
, and
control groups. Significant differences in the histopathology of the
kidney and fetus were observed between E. coli
Dr+- and E. coli Dr
-infected
pregnant mice. Histopathology of the placental sections of the E. coli Dr+ group showed massive infiltration of
bacteria, causing increased inflammation with very few villi left. In
the E. coli Dr
group, a majority of the
animals showed no inflammation and only a few showed minimal
inflammation in the placenta. However, this minimal inflammation did
not affect the pregnancy outcome or fetal birth weight in this group of mice.
In addition to virulence factors of the invading pathogen, host factors
such as genetic background, LPS hyporesponsivness, or cytokine
responses may also be critical for induction of pathogenicity. We
believe host responses to infection with E. coli
Dr+ differ from the host responses generated as a result of
infection with E. coli Dr
. Clearance of
bacteria and minimal pathology seen in the tissues from animals
infected with E. coli Dr
strain may be results
of optimum protective responses generated in response to this
bacterium. Recently, we have observed increased levels of
proinflammatory cytokine responses (in splenic and local [kidney and
placental] tissues) in the E. coli Dr+-infected
group compared to the E. coli Dr
-infected
group of pregnant animals (23). These increased inflammatory responses in pregnant animals seem to be responsible for the adverse outcomes observed in these animals. Smith et al. (40)
reports that increased apoptosis occurs in patients with intra-uterine growth retardation (40). It remains to be seen whether
proinflammatory cytokines generated in response to E. coli
Dr+ infection in this model are involved in apoptosis of
trophoblastic cells leading to fetal loss.
Recently, we observed a differential pregnancy outcome in LPS-responder C3H/HeN mice and LPS-nonresponder C3H/HeJ mice when infected with E. coli Dr+. The majority of C3H/HeJ mice developed preterm labor, whereas none of the C3H/HeN mice developed preterm labor (22). Thus, the host factor LPS response may also be an important factor for the generation of this acute response in E. coli Dr+-infected C3H/HeJ mice leading to preterm delivery. This model raises some important questions that may have implications in human pregnancy, for example, it may be significant to investigate whether there is a transient LPS hyporesponsiveness in patients delivering preterm in response to bacterial infections, particularly in light of the recent report about LPS hyporesponse in surgical patients (18).
This study demonstrates the association of gestational UTI by E. coli Dr+ with preterm delivery, low birth weight, and fetal mortality in C3H/HeJ mice. This model could serve as a means of investigating the biomolecular processes involved in infection-induced preterm parturition. The survival of the fetomaternal unit depends on a complex network of mechanisms that can be disrupted by any infection. It has been reported that the infection of the reproductive tract can have a direct effect of the infection on the placenta (43). However, this study shows that gestational UTI can also have a detrimental effect on the fetus. Both local and systemic responses of the host and the fetus in response to infection may contribute to the complications of preterm delivery.
| |
ACKNOWLEDGMENTS |
|---|
We thank Bogdan Nowicki of the Department of Obstetrics and Gynecology of The University of Texas Medical Branch, Galveston, Texas, for providing E. coli isolates and Bharat Kachroo for assistance with E. coli cultures. We also thank Deborah Sowells and Kristen Schmidt for assistance in the preparation of the manuscript.
This work was supported in part by grants by Hennepin Faculty Associates Research Award (to M.G.M. and V.R.L.) and National Kidney Foundation Young Investigator Award (to R.K. in 1998).
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Department of Obstetrics and Gynecology, Minneapolis Medical Research Foundation, D-3, 914 South Eighth St., Minneapolis, MN 55404. Phone: (612) 347-6847. Fax: (612) 347-4419. E-mail: kaulx005{at}tc.umn.edu.
Editor: P. E. Orndorff
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Andrews, W. W., S. M. Cox, and L. C. Gilstrap. 1990. Urinary tract infections in pregnancy. Int. Urogynecol. J. 1:155-163. |
| 2. | Barbara, L. 1995. Preventing preterm birth. Times Books, New York, N.Y. |
| 3. | Beachey, E. H. 1981. Bacterial adherence/adhesin receptor interactions mediating the attachment of bacteria of mucosal surfaces. J. Infect. Dis. 143:325-345[Medline]. |
| 4. |
Cousins, L. M.,
C. J. Habel,
R. J. Chang,
D. M. Okada, and J. R. Marshall.
1977.
Serum progesterone and estradiol-17 in premature and term labor.
Am. J. Obstet. Gynecol.
127:612-615[Medline].
|
| 5. | Cox, S. M., P. C. MacDonald, and M. L. Casey. 1988. Assay of bacterial endotoxin (LPS) in human amniotic fluid: potential usefulness in diagnosis and treatment of preterm labor. Am. J. Obstet. Gynecol. 159:99-106[Medline]. |
| 6. | Cunningham, F. G., P. C. MacDonald, N. F. Grant, K. J. Leveno, and L. C. Gilstrap, III. 1993. Renal and urinary tract disease, p. 1128-1130. In Williams obstetrics, 19th ed. Appleton and Lange, Norwalk, Conn. |
| 7. |
de Man, P.,
C. Van Kooten,
L. Aarden,
C. Svanborg-Eden,
I. Engberg, and H. Linder.
1989.
Interleukin-6 induced by gram-negative bacterial infection at mucosal surfaces.
Infect. Immun.
57:3383-3388 |
| 8. | de Man, P., U. Jodal, and C. Svanborg-Eden. 1991. Dependence among host response parameters used to diagnose urinary tract infection. J. Infect. Dis. 163:331-335[Medline]. |
| 9. | de Man, P., U. Jodal, K. Lincoln, and C. Svanborg-Eden. 1998. Bacterial attachment and inflammation in the urinary tract. J. Infect. Dis. 158:29-35. |
| 10. | Donnenberg, M. S., and R. A. Welch. 1996. Virulence determinants of uropathogenic Escherichia coli, p. 135-174. In H. L. T. Mobley, and J. W. Warren (ed.), Urinary tract infection: molecular pathogenesis and clinical management. American Society for Microbiology, Washington, D.C. |
| 11. |
Dyson, D. C.,
K. H. Danbe,
J. A. Bamber,
Y. M. Crites,
D. R. Field,
J. A. Maier,
L. A. Newman,
D. A. Ray,
D. L. Walton, and M. A. Armstrong.
1998.
Monitoring women at risk for preterm labor.
N. Engl. J. Med.
338:15-19 |
| 12. | Fidel, P., Jr., R. Romero, N. Wolf, J. Cutright, M. Ramirez, H. Araneda, and D. B. Cotton. 1994. Systemic and local cytokine profiles in endotoxin-induced preterm parturition in mice. Am. J. Obstet. Gynecol. 170:1467-1475[Medline]. |
| 13. |
Fortunato, S.,
R. P. Menon,
K. F. Swan, and R. Menon.
1996.
Inflammatory cytokine (interleukins 1, 6, and 8 and tumor necrosis factor- ) release from cultured human fetal membranes in response to endotoxic lipopolysaccharide mirrors amniotic fluid concentrations.
Am. J. Obstet. Gynecol.
174:1855-1862[Medline].
|
| 14. | Foxman, B., L. Shang, P. Tallman, K. Palin, C. Rode, C. Bloch, B. Gillespie, and C. F. Marrs. 1995. Virulence characteristics of Escherichia coli causing first urinary tract infection predict risk of second infection. J. Infect. Dis. 172:1536-1541[Medline]. |
| 15. | Goluszko, P., S. L. Moseley, L. D. Truong, A. Kaul, J. R. Willford, R. Selvarangan, S. Nowicki, and B. Nowicki. 1997. Development of experimental model of chronic pyelonephritis with Escherichia coli O75:K5:H-bearing Dr fimbriae. J. Clin. Invest. 99:1662-1672[Medline]. |
| 16. | Goluszko, P., V. Popov, R. Selvarangan, S. Nowicki, T. Pham, and B. J. Nowicki. 1997. Dr fimbriae operon of uropathogenic Escherichia coli mediate microtubule-dependent invasion to the HeLa epithelial cell line. J. Infect. Dis. 176:158-167[Medline]. |
| 17. | Harris, R. E., and L. C. Gilstrap. 1981. Cystitis during pregnancy: a distinct clinical entity. Obstet. Gynecol. 57:578-580[Medline]. |
| 18. | Haupt, W., J. Riese, C. Mehler, K. Weber, M. Zowe, and W. Hohenberger. 1998. Monocyte function before and after surgical trauma. Dig. Surg. 15:102-104[Medline]. |
| 19. |
Johnson, J. R.
1991.
Virulence factors in Escherichia coli urinary tract infection.
Clin. Microbiol. Rev.
4:80-128 |
| 20. | Kaga, N., Y. Katsuki, M. Obata, and Y. Shibutani. 1996. Repeated administration of low-dose LPS induces preterm delivery in mice: a model for human preterm parturition and for assessment of the therapeutic ability of drugs against preterm delivery. Am. J. Obstet. Gynecol. 174:754-759[Medline]. |
| 21. | Kaul, A. K., B. J. Nowicki, M. G. Martens, P. Golusko, A. Hart, M. Nagamani, D. Kumar, T. Q. Pham, and S. Nowicki. 1994. Decay-accelerating factor is expressed in the human endometrium and may serve as the attachment ligand for Dr pilli of E. coli. Am. J. Reprod. Immunol. 32:194-199. |
| 22. | Kaul, R., S. Khan, M. Martens, J. Crosson, and A. Kaul. 1999. Pregnancy outcome in LPS responder and non-responder mice infected with Dr adhesin bearing Escherichia coli. Am. J. Reprod. Immunol. 41:389. (Abstr. H-0-15.) |
| 23. | Kaul, R., S. Khan, M. Martens, J. Crosson, B. Kachroo, and A. Kaul. 1999. Role of cytokines in experimental model of gestational pyelonephritis leading to preterm delivery. Clin. Immunol. 90:449-450. (Abstr. H-86.) |
| 24. | Krieger, J. N. 1986. Complications and treatment of urinary tract infections during pregnancy. Urol. Clin. N. Am. 13:685-693[Medline]. |
| 25. | Krohn, M. A., S. S. Thwin, L. K. Rabe, Z. Brown, and S. L. Hellier. 1997. Vaginal colonization of E. coli as a risk factor for very low birth weight delivery and other perinatal complications. J. Infect. Dis. 175:606-610[Medline]. |
| 26. | Martens, M., A. K. Kaul, S. Nowicki, and P. Goluszko. 1993. Presence of receptors for Dr-hemagglutinin of uropathogenic E. coli in the uterus of pregnant rats. Poster presented at the 3rd World Congress for Infectious Diseases in OB/GYN, Acapulco, Mexico. |
| 27. |
Mazor, M.,
R. Hershkovitz,
W. Chaim,
J. Levy,
Y. Sharony,
J. Leiberman, and M. Glezerman.
1994.
Human preterm birth is associated with systemic and local changes in progesterone/17 -estradiol ratios.
Am. J. Obstet. Gynecol.
1:221-236.
|
| 28. | Millar, L. K., and S. M. Cox. 1996. Urinary tract infections complicating pregnancy. Infect. Dis. Clin. N. Am. 11:13-26[Medline]. |
| 29. | Naeye, R. L. 1986. Urinary tract infections and the outcome of pregnancy. Adv. Nephrol. 15:95-102. |
| 30. | Nowicki, B., L. Faug, J. Singhal, S. Nowicki, and C. Yallampalli. 1997. Lethal outcome of uterine infection in pregnant but not in nonpregnant rats and increased death ratio with inhibition of nitric oxide. Am. J. Reprod. Immunol. 38:309-312. |
| 31. |
Nowicki, B.,
J. Moulds,
R. Hull, and S. Hull.
1988.
A hemagglutinin of uropathogenic Escherichia coli recognizes the Dr blood group antigen.
Infect. Immun.
56:1057-1060 |
| 32. | Nowicki, B. J. 1996. In vitro models for the study of uropathogens in urinary tract infections, p. 341-376. In H. L. T. Mobley, and J. W. Warren (ed.), Urinary tract infections: molecular pathogenesis and clinical management. American Society for Microbiology, Washington, D.C. |
| 33. |
Nowicki, B. J.,
A. Hart,
K. E. Coyne,
D. M. Lublin, and S. Nowicki.
1993.
Short consensus repeat-3 domain of recombinant decay-accelerating factor is recognized by Escherichia coli recombinant Dr adhesin in a model of a cell-cell interaction.
J. Exp. Med.
178:2115-2121 |
| 34. | Nowicki, B. J., H. Holthofer, T. Saraneva, M. Rhen, V. Vaisasen-Rhen, and T. K. Korhonen. 1986. Location of adhesion sites for P-fimbriated and for O75X-positive Escherichia coli in the human kidney. Microb. Pathog. 1:169-180[Medline]. |
| 35. | Nowicki, B. J., L. Truong, J. Moulds, and R. Hull. 1988. Presence of Dr receptor in normal human tissues and its possible role in the pathogenesis of ascending urinary tract infection. Am. J. Pathol. 133:1-4[Abstract]. |
| 36. | Nowicki, B. J., M. G. Martens, A. Hart, and S. Nowicki. 1994. Gestational age dependent distribution of E. coli fimbriae in pregnant patients with pyelonephritis. Ann. N. Y. Acad. Sci. 730:290-291[Medline]. |
| 37. | Romero, R., E. Oyarzun, M. Mazor, M. Sirtori, J. C. Hobbins, and M. Bracken. 1989. Meta-analysis of the relationship between asymptomatic bacteriuria and preterm delivery/low birth weight. Obstet. Gynecol. 73:576-582[Medline]. |
| 38. | Schultz, R., A. W. Read, J. Straton, F. J. Stanley, and P. Morich. 1991. Genito urinary tract infection in pregnancy and low birth weight: case control study in Australian Aboriginal women. Brit. Med. J. 303:1369-1373. |
| 39. | Silver, R. M., S. S. Edwin, and M. S. Trautman. 1995. Bacterial LPS mediated fetal death: production of a newly-recognized form of inducible cycloxygenase (COX-2) in murine decidua in response to LPS. J. Clin. Invest. 95:725-731. |
| 40. | Smith, S. C., P. N. Baker, and E. M. Symonds. 1997. Increased placental apoptosis in intrauterine growth restriction. Am. J. Obstet. Gynecol. 177:1395-1401[Medline]. |
| 41. | Svanborg, C., and G. Godaly. 1997. Bacterial virulence in urinary tract infection. Infect. Dis. Clin. N. Am. 11:513-529[Medline]. |
| 42. | Svanborg, E. C. 1986. Bacterial adherence in urinary tract infections caused by E. coli. Scand. J. Urol. Nephrol. 20:81-88[Medline]. |
| 43. | Sweet, R. L., and R. S. Gibbs. 1990. Infectious diseases of the female genital tract, p. 442-445. Williams & Wilkins, Baltimore, Md. |
| 44. | Warren, J. W. 1996. Clinical presentation and epidemiology of urinary tract infections, p. 3-27. In H. L. T. Mobley, and J. W. Warren (ed.), Urinary tract infections: molecular pathogenesis and clinical management. American Society for Microbiology, Washington, D.C. |
| 45. | Westerlund, B., P. Kuusela, J. Risteli, T. Vartio, H. Rauvala, R. Virkola, and T. K. Korhonen. 1989. The O75X adhesin of uropathogenic Escherichia coli is a type IV collagen-binding protein. Mol. Microbiol. 3:329-337[Medline]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»